Latest news
Vaxcellbio Partners with Myellama to Advance Next-Generation NK Cell Therapy for Multiple Myeloma - BioPharma APACBioPharma APAC · Tue, 04 Aug 2026 18:34:56 GMTVaxcellbio launches global co-development program for NRC-based NK cell therapy for multiple myeloma - koreabiomed.comkoreabiomed.com · Tue, 04 Aug 2026 06:22:28 GMTAribio and ForeverNK join to develop next-gen Alzheimer’s drugs in South Korea - CHOSUNBIZ - ChosunbizChosunbiz · Mon, 27 Jul 2026 07:00:00 GMT